EUVIMEDEUVIMED entdecken
Crossref

Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment

Josef Rabl, Michael Specka, Udo Bonnet, Özge Irtürk, Fabrizio Schifano, Norbert Scherbaum

Pharmacopsychiatry · 01.03.2025 · 58 (02) · 88-94

DOI: 10.1055/a-2414-5867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 01.03.2025. Verfasst von Josef Rabl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Johannesbad Kliniken Fredeburg GmbH, Schmallenberg, Germany. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Electronic Nicotine Delivery Systems, Smoking Cessation, Opiate Substitution Treatment. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

As tobacco smoking decreases, the use of e-cigarettes is on the rise. There is a debate whether switching from smoking to the use of e-cigarettes might represent a harm reduction strategy for those who smoke tobacco heavily, a habit often observed in individuals with opioid dependence. The present study investigated the prevalence and patterns of tobacco smoking and e-cigarette use in patients in opioid maintenance treatment (OMT) and whether e-cigarette use contributed to the cessation of smoking tobacco.

Methods

In 2014 (n=84) and in 2021 (n=128), patients from two OMT clinics of a psychiatric university hospital were interviewed Results In both surveys, patients presented with a comparable average age (45.6 vs. 46.9 years of age), gender distribution (mainly male 71.4 vs. 75.8%), and length of OMT history (median: 66 vs. 55 months). The lifetime prevalence of e-cigarette use (45.2% in 2014 and 38.3% in 2021) was much higher than the current prevalence (4.9% and 7.8%, respectively). Few patients reported either a complete switch from smoking to the use of e-cigarettes (2014, n=1 vs. 2021, n=2) or the achievement of abstinence from smoking after a temporary use of e-cigarettes (2014, n=2 vs. 2021, n=1).

Discussion

No increase in the use of e-cigarettes was observed in these groups of patients undergoing OMT. Presumably, harm reduction strategies relating to the use of e-cigarettes in this group need to be supported by motivational interventions. Given the high morbidity and mortality due to smoking, OMT clinics should offer professional help in reducing smoking.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersElectronic Nicotine Delivery SystemsSmoking CessationOpiate Substitution TreatmentVapingHumansMaleFemaleMiddle AgedAdultPrevalence

Autor:innen und Institutionen

  • Johannesbad Kliniken Fredeburg GmbH, Schmallenberg, Germany.
  • LVR-University Hospital Essen, Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
  • Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Evangelisches Krankenhaus Castrop-Rauxel, Academic Teaching Hospital of the University of Duisburg-Essen, Castrop-Rauxel, Germany.
  • University of Hertfordshire, Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, Hatfield, Hertfordshire, UK.

Zitieren

APA

Rabl, J., Specka, M., Bonnet, U., Irtürk, Ö., Schifano, F., & Scherbaum, N. (2025). Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment. Pharmacopsychiatry, 58(02), 88-94. https://doi.org/10.1055/a-2414-5867

Vancouver

Rabl J, Specka M, Bonnet U, Irtürk Ö, Schifano F, Scherbaum N. Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment. Pharmacopsychiatry. 2025;58(02):88-94. doi:10.1055/a-2414-5867

BibTeX
@article{Rabl2025,
  author = {Rabl, Josef and Specka, Michael and Bonnet, Udo and Irtürk, Özge and Schifano, Fabrizio and Scherbaum, Norbert},
  title = {Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment},
  journal = {Pharmacopsychiatry},
  year = {2025},
  volume = {58},
  number = {02},
  pages = {88--94},
  doi = {10.1055/a-2414-5867}
}
Kostenlos starten →